Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Economics 3

With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunother…